PRiME was established at the University of Toronto in 2019 to align research efforts in the area of precision medicine, bringing together multi-disciplinary talent including world-class investigators across U of T, affiliated hospitals, and global academic and industry partners to face and answer emerging challenges in precision medicine by understanding the biology of disease, creating new tools for disease diagnosis, and developing novel therapeutic strategies.
Mission
Grow interdisciplinary international research, training and translation pipelines that propel promising therapeutics towards patients.
Vision
Build inclusive, interdisciplinary global research hubs that redefine how next-generation precision medicine is discovered, developed, and delivered.
Strategic Priorities:
- Catalyze first-in-class research by enabling deep interdisciplinary collaborative research across drug discovery, delivery, diagnostics, computation, and disease biology, and embedding ideas to impact pathways from project inception.
- Foster entrepreneurship towards venture creation and growth.
- Drive translational outcomes through seamless integration with affiliated hospitals, commercialization partners, and industry throughout the research lifecycle.
- Strengthen training and talent development that integrates scientific excellence with translational, entrepreneurial, and industry-relevant skills.
- Embed Equity, Diversity, & Inclusion best practices across all Precision X hubs.
[PRiME is] an ambitious and groundbreaking collaborative initiative at the frontiers of medical research and innovation. It is the kind of initiative needed to tackle complex research problems and to undertake the clinical translation and commercialization that are so criticial to have lasting impact.
Meric Gertler
President of the University of Toronto.